Research from Blue Health Intelligence® (BHI®) found that skin cancer and melanoma rates differed widely from state to state. This brief examines the rate of skin cancer and melanoma occurrence across the U.S. in 2019.
The number of individuals with high-cost and very high-cost medical claims is continuing to grow, consuming more and more of the total healthcare spend in the United States. The ability to predict which individuals are on a path to high cost, and which interventions have the best chance of preventing that eventuality, has become critically important.
Almost $1 of every $3 spent in healthcare is wasted on services that have little or no clinical benefit, are potentially harmful, or are delivered in unnecessary high-cost settings. The potential to harm patients may stem directly from the risks of LVC, or indirectly from additional tests and procedures that contain risks and/or have little or no clinical benefit. Blue … Read More